Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2006 2
2008 1
2010 1
2011 1
2013 3
2014 5
2015 5
2016 2
2017 3
2018 6
2019 4
2020 8
2021 9
2022 4
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Real life experience of tafamidis for the treatment of Spanish patients with Val30Met transthyretin amyloidosis with polyneuropathy.
Sanso MAR, Rodriguez AR, Vicente LM, Sevilla T, Garro CB, Martín JF, Vicente AA, de la Prida MM, Dávila LG, Vázquez LG, Valle FM, Pons CC, Bau AF, Barroso EC, López IL, González-Moreno J. Sanso MAR, et al. Among authors: rodriguez ar. Med Clin (Barc). 2024 Mar 30:S0025-7753(24)00080-0. doi: 10.1016/j.medcli.2024.01.008. Online ahead of print. Med Clin (Barc). 2024. PMID: 38556397 English, Spanish.
Validating the usefulness of Sudoscan in ATTRv: a single centre experience.
Moreno-Moraleda E, González-Moreno J, Cisneros-Barroso E, Ribot-Sansó MA, Ripoll-Vera T, Descals C, Uson M, Montalà JC, Figuerola A, Rodríguez A, Losada I. Moreno-Moraleda E, et al. Among authors: rodriguez a. Neurol Sci. 2024 Jan 23. doi: 10.1007/s10072-024-07311-3. Online ahead of print. Neurol Sci. 2024. PMID: 38261153
Biomarkers of axonal damage to favor early diagnosis in variant transthyretin amyloidosis (A-ATTRv).
González-Moreno J, Gragera-Martínez Á, Rodríguez A, Borrachero-Garro C, García-Garrido S, Barceló C, Manovel-Sánchez A, Ribot-Sansó MA, Ibargüen-González L, Gomila R, Muñoz-Beamud F, Losada-López I, Cisneros-Barroso E. González-Moreno J, et al. Among authors: rodriguez a. Sci Rep. 2024 Jan 5;14(1):581. doi: 10.1038/s41598-023-50212-2. Sci Rep. 2024. PMID: 38182630 Free PMC article.
Biohybrid Hydrogels for Tumoroid Culture.
Castellote-Borrell M, Merlina F, Rodríguez AR, Guasch J. Castellote-Borrell M, et al. Among authors: rodriguez ar. Adv Biol (Weinh). 2023 Dec;7(12):e2300118. doi: 10.1002/adbi.202300118. Epub 2023 Jul 28. Adv Biol (Weinh). 2023. PMID: 37505458 Review.
Elevated complement C3 and increased CD8 and type 1 helper lymphocyte T populations in patients with post-COVID-19 condition.
Garcia-Gasalla M, Berman-Riu M, Rodriguez A, Iglesias A, Fraile-Ribot PA, Toledo-Pons N, Pol-Pol E, Ferré-Beltrán A, Artigues-Serra F, Martin-Pena ML, Pons J, Murillas J, Oliver A, Riera M, Ferrer JM. Garcia-Gasalla M, et al. Among authors: rodriguez a. Cytokine. 2023 Sep;169:156295. doi: 10.1016/j.cyto.2023.156295. Epub 2023 Jul 14. Cytokine. 2023. PMID: 37453328 Free article.
Accessibility to Occupational Therapy Services for Hereditary Transthyretin Amyloidosis.
Gayà-Barroso A, González-Moreno J, Rodríguez A, Ripoll-Vera T, Losada-López I, Gili M, Cisneros-Barroso E. Gayà-Barroso A, et al. Among authors: rodriguez a. Int J Environ Res Public Health. 2022 Apr 7;19(8):4464. doi: 10.3390/ijerph19084464. Int J Environ Res Public Health. 2022. PMID: 35457333 Free PMC article.
Hyperinflammatory State and Low T1 Adaptive Immune Response in Severe and Critical Acute COVID-19 Patients.
Garcia-Gasalla M, Berman-Riu M, Pons J, Rodríguez A, Iglesias A, Martínez-Pomar N, Llompart-Alabern I, Riera M, Ferré Beltrán A, Figueras-Castilla A, Murillas J, Ferrer JM. Garcia-Gasalla M, et al. Among authors: rodriguez a. Front Med (Lausanne). 2022 Mar 29;9:828678. doi: 10.3389/fmed.2022.828678. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35425776 Free PMC article.
57 results